Chemically-defined albumin-free differentiation of human pluripotent stem cells to endothelial progenitor cells

Stem Cell Research

Volumn 15, Issue 1, 2015, Pages 122-129

  Bao, Xiaoping ^a   Lian, Xiaojun ^a,b   Dunn, Kaitlin K ^a   Shi, Mengxuan ^a   Han, Tianxiao ^a   Qian, Tongcheng ^a   Bhute, Vijesh J ^a   Canfield, Scott G ^a   Palecek, Sean P ^a  

^a Wisconsin Electric Machines and Power Electronics Consortium   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ALBUMIN; ASCORBIC ACID; CALPONIN; CD31 ANTIGEN; CD34 ANTIGEN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; MYOSIN HEAVY CHAIN; SMOOTH MUSCLE ACTIN; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR; WNT PROTEIN; ALBUMINOID; CULTURE MEDIUM; LEUKOCYTE ANTIGEN;

ALBUMIN FREE MEDIUM; ARTICLE; CELL DIFFERENTIATION; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAGNETIC ACTIVATED CELL SORTING; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WNT SIGNALING PATHWAY; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; MULTIPOTENT STEM CELL; PHARMACOLOGY;

ALBUMINS; ANTIGENS, CD; CELL DIFFERENTIATION; CULTURE MEDIA; ENDOTHELIAL PROGENITOR CELLS; HUMANS; MULTIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS;

EID: 84930945666     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2015.05.004     Document Type: Article

References (26)

1. Ashman N., Harwood S.M., Kieswich J., Allen D.A., Roberts N.B., Mendes-Ribeiro A.C., Yaqoob M.M. Albumin stimulates cell growth, l-arginine transport, and metabolism to polyamines in human proximal tubular cells. Kidney Int. 2005, 67:1878-1889.
2. Ashton R.S., Keung A.J., Peltier J., Schaffer D.V. Progress and prospects for stem cell engineering. Annu. Rev. Chem. Biomol. Eng. 2011, 2:479-502.
3. Bautch V.L. Stem cells and the vasculature. Nat. Med. 2011, 17:1437-1443.
4. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., Smuga-Otto K., Howden S.E., Diol N.R., Propson N.E., Wagner R., Lee G.O., Antosiewicz-Bourget J., Teng J.M.C., Thomson J.A. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
5. Garcia-Gonzalo F.R., Izpisúa Belmonte J.C. Albumin-associated lipids regulate human embryonic stem cell self-renewal. PLoS One 2008, 3:e1384.
6. Goldman O., Feraud O., Boyer-Di Ponio J., Driancourt C., Clay D., Le Bousse-Kerdiles M.-C., Bennaceur-Griscelli A., Uzan G. A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 2009, 27:1750-1759.
7. James D., Nam H., Seandel M., Nolan D., Janovitz T., Tomishima M., Studer L., Lee G., Lyden D., Benezra R., Zaninovic N., Rosenwaks Z., Rabbany S.Y., Rafii S. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat. Biotechnol. 2010, 28:161-166.
8. Kinney M.A., Hookway T.A., Wang Y., McDevitt T.C. Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics. Ann. Biomed. Eng. 2014, 42:352-367.
9. Kusuma S., Macklin B., Gerecht S. Derivation and network formation of vascular cells from human pluripotent stem cells. Methods Mol. Biol. 2014, 1202:1-9.
10. Lian X.J., Hsiao C., Wilson G., Zhu K.X., Hazeltine L.B., Azarin S.M., Raval K.K., Zhang J.H., Kamp T.J., Palecek S.P. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1848-E1857.
11. Lian X., Selekman J., Bao X., Hsiao C., Zhu K., Palecek S.P. A small molecule inhibitor of SRC family kinases promotes simple epithelial differentiation of human pluripotent stem cells. PLoS One 2013, 8:e60016.
12. Lian X., Zhang J., Azarin S.M., Zhu K., Hazeltine L.B., Bao X., Hsiao C., Kamp T.J., Palecek S.P. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 2013, 8:162-175.
13. Lian X., Bao X., Al-Ahmad A., Liu J., Wu Y., Dong W., Dunn K.K., Shusta E.V., Palecek S.P. Efficient Differentiation of Human Pluripotent Stem Cells to Endothelial Progenitors via Small-Molecule Activation of WNT Signaling. Stem Cell Rep. 2014, 3:804-816.
14. Marcelo K.L., Sills T.M., Coskun S., Vasavada H., Sanglikar S., Goldie L.C., Hirschi K.K. Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control. Dev. Cell 2013, 27:504-515.
15. May J.M., Harrison F.E. Role of vitamin C in the function of the vascular endothelium. Antioxid. Redox Signal. 2013, 19:2068-2083.
16. Montecinos V., Guzmán P., Barra V., Villagrán M., Muñoz-Montesino C., Sotomayor K., Escobar E., Godoy A., Mardones L., Sotomayor P., Guzmán C., Vásquez O., Gallardo V., van Zundert B., Bono M.R., Oñate S.A., Bustamante M., Cárcamo J.G., Rivas C.I., Vera J.C. Vitamin C is an essential antioxidant that enhances survival of oxidatively stressed human vascular endothelial cells in the presence of a vast molar excess of glutathione. J. Biol. Chem. 2007, 282:15506-15515.
17. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
18. Piecewicz S.M., Pandey A., Roy B., Xiang S.H., Zetter B.R., Sengupta S. Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS One 2012, 7:e32191.
19. Rufaihah A.J., Huang N.F., Jamé S., Lee J.C., Nguyen H.N., Byers B., De A., Okogbaa J., Rollins M., Reijo-Pera R., Gambhir S.S., Cooke J.P. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31:e72-e79.
20. Sahara M., Hansson E.M., Wernet O., Lui K.O., Später D., Chien K.R. Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells. Cell Res. 2014, 24:820-841.
21. Segers V.F.M., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
22. Wang L., Li L., Shojaei F., Levac K., Cerdan C., Menendez P., Martin T., Rouleau A., Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004, 21:31-41.
23. Wang Z.Z., Au P., Chen T., Shao Y., Daheron L.M., Bai H., Arzigian M., Fukumura D., Jain R.K., Scadden D.T. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 2007, 25:317-318.
24. Wilson H.K., Canfield S.G., Shusta E.V., Palecek S.P. Concise review: Tissue-specific microvascular endothelial cells derived from human pluripotent stem cells. Stem Cells 2014, 32:3037-3045.
25. Zhao L., Cao F., Yin T., Sun D., Cheng K., Zhang J., Wang H. Moderate dose insulin promotes function of endothelial progenitor cells. Cell Biol. Int. 2011, 35:215-220.
26. Zoellner H., Höfler M., Beckmann R., Hufnagl P., Vanyek E., Bielek E., Wojta J., Fabry A., Lockie S., Binder B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J. Cell Sci. 1996, 109(Pt 10):2571-2580.